Diplomat Specialty Pharmacy® and Diplomat Specialty Infusion Group® are joining the Optum® family.
To learn more about what this means for you, visit our FAQ pages:
RIASTAP®
RiaSTAP®FDA INDICATION: For the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. Package Insert
CLASS: Human
DISTRIBUTOR: CSL Behring
ROUTE OF ADMINISTRATION: Intravenous
ASSAY SIZES (mg): 900–1300
DILUENT SIZE: 50 mL
STORAGE: When stored at temperatures of 2–25°C (36–77°F), RiaSTAP is stable for the period indicated by the expiration date on the carton and vial label (up to 60 months). Do not freeze. Protect from light
HALF-LIFE: 78.7 ± 18.13 hours
OTHER WEBSITES: riastap.com